Injectable Semaglutide, Efpeglenatide Led MACE Profiles in T2DM Tags Coronary artery disease Stroke GLP-1 agonists Read more about Injectable Semaglutide, Efpeglenatide Led MACE Profiles in T2DM
T2DM Subtypes Showed Distinct Dementia and Stroke Risks Tags Diabetic Neuropathy Stroke Read more about T2DM Subtypes Showed Distinct Dementia and Stroke Risks
AACE 2026: IDA May Distort A1C Readings in Stroke Patients With T2DM Tags Hypoglycemia Stroke hBA1c Read more about AACE 2026: IDA May Distort A1C Readings in Stroke Patients With T2DM
TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM Tags Myocardial infarction Peripheral vascular disease Stroke DPP-4 inhibitors Thiazolidinediones Read more about TZD and SGLT2i Outperform DPP-4i After Revascularization in T2DM
Type 2 Diabetes Tied to Worse Nighttime Autonomic Function After Stroke Tags Electrocardiogram Stroke hBA1c Read more about Type 2 Diabetes Tied to Worse Nighttime Autonomic Function After Stroke
SGLT2i Use Shows Lower Stroke Risk in T2D With Retinopathy Tags Stroke hBA1c SGLT-2 Inhibitor Read more about SGLT2i Use Shows Lower Stroke Risk in T2D With Retinopathy
Empagliflozin or Dapagliflozin for Cardiorenal Outcomes in T2DM? Tags Myocardial infarction Stroke SGLT-2 Inhibitor Read more about Empagliflozin or Dapagliflozin for Cardiorenal Outcomes in T2DM?
Low-Dose Colchicine Reduces MACE Risk in Diabetes Tags Myocardial infarction Stroke Read more about Low-Dose Colchicine Reduces MACE Risk in Diabetes
Waist-to-Height Ratio Reveals Cardiovascular Risk in T2DM Tags Myocardial infarction Stroke Read more about Waist-to-Height Ratio Reveals Cardiovascular Risk in T2DM
Higher Basal Metabolic Rate Linked to Diabetes Risk in Cohort Tags CRP Diabetic ketoacidosis Diabetic coma Coronary artery disease Stroke hBA1c Read more about Higher Basal Metabolic Rate Linked to Diabetes Risk in Cohort